When you use a comprehensive, compatible1 solution, you’re set for success to make quick decisions in the fight against acute ischemic stroke.
When time is brain, there’s no need to think twice about your procedural decisions when you need to act fast. With Solitaire Thrombectomy + Aspiration Therapy (STAT), you’ve got greater freedom and flexibility using our comprehensive, compatible portfolio of Solitaire, React™ and Riptide™.
Partner with Medtronic and focus on what matters — the urgent care you need to provide — to give patients a better chance to walk away from an acute ischemic stroke (AIS).
A combined approach by SR + CA proved to be associated with a better percentage of FPE (First Pass Effect).6
The ability to combine these powerful technologies — Solitaire, Phenom™, React and Riptide — means you can have true peace of mind knowing you can use these solutions together, on-label, if and when you need them.
STAT is comprised of:
* Clinical studies include Solitaire Platinum Revascularization Device and Solitaire Revascularization Device. React and Riptide were not included.
SOLITAIRE + REACT:
With STAT, you are set up to make quick decisions in the fight against AIS.
The Solitaire X revascularization device, featuring Parametric™ design, a unique overlapping stent retriever-based technology, restores blood flow and retrieves clots from occluded blood vessels in the brain for patients experiencing acute ischemic stroke (AIS) due to a large vessel occlusion (LVO).
The Solitaire device is indicated to reduce stroke-related disability by showing nearly 70% relative improvement in functional outcomes at 90 days in patients suffering LVO.5
The React Catheter features a coil and braid design along with end-to-end Nitinol construction—easing navigation to the M1 and M2 segments. This catheter combined with the Solitaire device and the Riptide Aspiration System is designed to revascularize patients experiencing acute ischemic stroke.
The Riptide Aspiration System is an aspiration thrombectomy system designed to retrieve a blood clot and restore blood flow to occluded vessels in the brain for patients experiencing acute ischemic stroke due to a large vessel occlusion.
ESCAPE, SWIFT PRIME, Nasa Registry, STRATIS, THRACE, MR CLEAN, STAR, EXTEND IA, HERMES, SEER, REVASCAT
TR-NV13807 Rev A
DWGS50969 Rev 7
71011-001 Rev 06/17
Di Maria et al. Identifying the predictors of first-pass effect and its influence on clinical outcome in the setting of endovascular thrombectomy for acute ischemic stroke: Results from a multicentric prospective registry. International Journal of Stroke. (0) 0 2020.
CAUTION: Federal (USA) law restricts these devices to sale distribution and use by or on order of a physician. Indications, contraindications, warnings and instructions for use for Solitaire™ X Revascularization Device can be viewed at www.medtronic.com/manuals. Indications, contraindications, warnings and instructions for all other products can be found in the product labeling supplied with each device.
The React™ 68 Catheter and React™ 71 Catheter are indicated for the introduction of interventional devices into the peripheral and neuro vasculature.
The Riptide™ Aspiration System is intended for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment.
Phenom™ Catheters are intended for the introduction of interventional devices and infusion of diagnostic or therapeutic agents into the neuro, peripheral, and coronary vasculatures.